相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies
A. Spreafico et al.
BRITISH JOURNAL OF CANCER (2015)
Heat shock protein vaccines against glioblastoma: from bench to bedside
Leonel Ampie et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
ATPS-05CHARACTERIZATION OF THE ACTIVITY OF AT13387, A NOVEL SECOND GENERATION HSP90 INHIBITOR AGAINST GLIOMAS
Alessandro Canella et al.
NEURO-ONCOLOGY (2015)
Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition
Ying Shen et al.
ONCOTARGET (2015)
Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27
Dong-ping Sang et al.
ACTA PHARMACOLOGICA SINICA (2014)
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Jigisha P. Thakkar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
HSP90 Supports Tumor Growth and Angiogenesis through PRKD2 Protein Stabilization
Ninel Azoitei et al.
CANCER RESEARCH (2014)
Quercetin promotes glioma growth in a rat model
Lauren L. Zamin et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Hsp90 inhibition enhances PI-3 kinase inhibition and radiosensitivity in glioblastoma
Phyllis R. Wachsberger et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Quercetin and Sorafenib as a Novel and Effective Couple in Programmed Cell Death Induction in Human Gliomas
Joanna Jakubowicz-Gil et al.
NEUROTOXICITY RESEARCH (2014)
Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells
S. Boridy et al.
CELL DEATH & DISEASE (2014)
Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines
Susanne Hartmann et al.
CANCER LETTERS (2013)
First-in-Human Phase I Dose-Escalation Study of the HSP90 Inhibitor AUY922 in Patients with Advanced Solid Tumors
Cristiana Sessa et al.
CLINICAL CANCER RESEARCH (2013)
Inhibition of HSP90 molecular chaperones: moving into the clinic
Rocio Garcia-Carbonero et al.
LANCET ONCOLOGY (2013)
Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the pediatric preclinical testing program
Richard B. Lock et al.
PEDIATRIC BLOOD & CANCER (2013)
Peptide aptamers: tools to negatively or positively modulate HSPB1(27) function
Benjamin Gibert et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2013)
Silencing of Hsp27 and Hsp72 in glioma cells as a tool for programmed cell death induction upon temozolomide and quercetin treatment
Joanna Jakubowicz-Gil et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
TRAP-1, the mitochondrial Hsp90
Dario C. Altieri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Len Neckers et al.
CLINICAL CANCER RESEARCH (2012)
Small heat shock proteins in cancer therapy and prognosis
Amina Zoubeidi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing program
Min H. Kang et al.
PEDIATRIC BLOOD & CANCER (2012)
Inhibition of heat shock protein 27 (HspB1) tumorigenic functions by peptide aptamers
B. Gibert et al.
ONCOGENE (2011)
Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction
L. Stingl et al.
BRITISH JOURNAL OF CANCER (2010)
The Novel Hsp90 Inhibitor NXD30001 Induces Tumor Regression in a Genetically Engineered Mouse Model of Glioblastoma Multiforme
Haihao Zhu et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Global Targeting of Subcellular Heat Shock Protein-90 Networks for Therapy of Glioblastoma
Markus D. Siegelin et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Mechanistic Evaluation of the Novel HSP90 Inhibitor NVP-AUY922 in Adult and Pediatric Glioblastoma
Nathalie Gaspar et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Preclinical Antitumor Activity of the Orally Available Heat Shock Protein 90 Inhibitor NVP-BEP800
Andrew J. Massey et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Heat shock factors: integrators of cell stress, development and lifespan
Malin Akerfelt et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy
Rudi Bao et al.
CLINICAL CANCER RESEARCH (2009)
BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90
Karen Lundgren et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90
Fiona A. Dungey et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells
Claire Marie-Elisabeth Sauvageot et al.
NEURO-ONCOLOGY (2009)
The heat shock protein antagonist 17-AAG potentiates the activity of enzastaurin against malignant human glioma cells
Esther P. Jane et al.
CANCER LETTERS (2008)
NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
Suzanne A. Eccles et al.
CANCER RESEARCH (2008)
HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion
William A. Golembieski et al.
GLIA (2008)
Protective role of Hsp27 protein against γ radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells
Marie-Therese Aloy et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Underlying mechanism of quercetin-induced cell death in human glioma cells
Eui Joong Kim et al.
NEUROCHEMICAL RESEARCH (2008)
Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G2/M arrest in glioblastoma cell lines
P. Garcia-Morales et al.
ONCOGENE (2007)
Regulation of tumor cell mitochondrial Homeostasis by an organelle-specific Hsp90 chaperone network
Byoung Heon Kang et al.
CELL (2007)
Phorbol 12-myristate 13-acetate (PMA)-induced migration of glioblastoma cells is mediated via p38MAPK/Hsp27 pathway
Naoko Nomura et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Inhibitors of the heat shock response: Biology and pharmacology
Marissa V. Powers et al.
FEBS LETTERS (2007)
Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells
Masayuki Kamada et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with 17-AAG on glioma cell growth
DR Premkumar et al.
MOLECULAR CARCINOGENESIS (2006)
Synergistic interaction between 17-AAG and phosphatidylinositol 3-kinase inhibition in human malignant glioma cells
DR Premkumar et al.
MOLECULAR CARCINOGENESIS (2006)
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
DR Ciocca et al.
CELL STRESS & CHAPERONES (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
EEA Bull et al.
CLINICAL CANCER RESEARCH (2004)
Geldanamycin inhibits migration of glioma cells in vitro:: A potential role for hypoxia-inducible factor (HIF-1α) in glioma cell invasion
D Zagzag et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats
MJ Egorin et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Modulation of Akt kinase activity by binding to Hsp90
S Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
